Resources library

Welcome to our resource library. We invite you to explore and view our extensive resources and information.

Infographic: The 7 Regulatory Milestones Every Viral Vector Developer Should Plan For

28 September, 2026 | Regulatory

A practical visual roadmap outlining the seven key regulatory milestones viral vector developers should consider from early development through lifecycle management.

View details >
Infographic: The 7 Regulatory Milestones Every Viral Vector Developer Should Plan For
Infographics

5 Questions with… Melanie Kearney

30 July, 2026 | Lentivirus, AAV, Adenovirus, Industry Insights, Regulatory, Quality

Quality is about more than compliance. It's about building confidence at every stage of development. In this edition of 5 Questions with..., Dr. Melanie Kearney, SVP, Global Head of Quality at OXB, explores why Quality should be embedded from the very beginning of a cell and gene therapy programme.

View Resource >
5 Questions with… Melanie Kearney
Articles

Structural Analysis of Recombinant AAV Vector Genomes at Single-Molecule Resolution

31 July, 2026 | AAV, Upstream Innovation

This paper presents a long-read analysis pipeline for accurately classifying recombinant AAV genome heterogeneity to improve vector characterization and design.

View details >
Structural Analysis of Recombinant AAV Vector Genomes at Single-Molecule Resolution
Journal Papers

5 Questions with… Ceri Schofield

30 July, 2026 | Lentivirus, AAV, Adenovirus, Industry Insights, Regulatory, Quality

How can Quality accelerate programme success while reducing risk? In this edition of 5 Questions with..., Ceri Schofield, VP and Head of Quality at OXB, shares her perspective on the increasingly strategic role of Quality in viral vector development.

View Resource >
Articles

An Engineered Helper Plasmid Generates Differential E4orf6 and L4-22/33K Gene Expression Increasing AAV Vector Production

10 August, 2026 | AAV, Upstream Innovation

Discover how engineered helper plasmids can increase AAV yields by up to fivefold while preserving vector quality, offering a scalable approach to more efficient AAV manufacturing.

View Resource >
Journal Papers

Podcast: Building quality at scale – How viral vector CDMOs stay inspection ready

29 April, 2026 | Lentivirus, AAV, Adenovirus, Industry Insights, Regulatory, Quality

Melanie Kearney, SVP and Global Head of Quality explores how connecting R&D and manufacturing earlier can prevent delays and unnecessary complexity, why audits don’t have to be something to “get through” but can actually become a competitive advantage, and how clear communication and continuous improvement help turn change into opportunity.

View details >
Webinars and Videos